While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding answers from the pharmaceutical giant they say left patients without an ...

We know that supplements that promise the world are, for the most part, nothing more than expensive fads, but wanted to ask ...

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

"And whether you're using Eli Lilly, Sanofi and Novo Nordisk products, your insulin costs will be $35 a month, period," he said. The agreement reached with Novo Nordisk covers popular brands like ...

In the case of insulin, if the generic is covered ... sometimes in place of a brand-name. These insulins fall into different categories, such as generic, unbranded and biosimilar.

In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...

In a September 20 statement the FTC wrote: "Insulin medications used to be affordable. In 1999, the average list price of Humalog—a brand-name insulin medication manufactured by Eli Lilly—was ...